Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;105(4):e160-e163.
doi: 10.3324/haematol.2019.227199. Epub 2019 Aug 8.

Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma

Thomas Mika  1 , Swetlana Ladigan  1 , Alexander Baraniskin  1 , Deepak Vangala  1 , Sabine Seidel  2 , Olaf Hopfer  3 , Michael Kiehl  4 , Roland Schroers  5
Affiliations

Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma

Thomas Mika et al. Haematologica. 2020 Apr.
No abstract available

PubMed Disclaimer

References

    1. Mendez JS, Grommes C. Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules. Am Soc Clin Oncol Educ Book. 2018(38):604–15. - PubMed
    1. Illerhaus G, Schorb E, Kasenda B. Novel agents for primary central nervous system lymphoma: evidence and perspectives. Blood. 2018; 132(7):681–688. - PubMed
    1. Nayak L, Iwamoto FM, LaCasce A, et al. PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma. Blood. 2017;129(23):3071–3073. - PMC - PubMed
    1. Varadi G, Or R, Kapelushnik J, et al. Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk Lymphoma. 1999; 34(1–2):185–190. - PubMed
    1. Kasenda B, Ihorst G, Schroers R, et al. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia. 2017; 31(12):2623–2629. - PubMed

MeSH terms